Gifthealth Announces Jeremy Richardson as New Chief Commercial Officer

Gifthealth has announced the appointment of Jeremy Richardson as its new Chief Commercial Officer (CCO).

Astoriom Appoints Will Edwards as Chief Executive Officer

Strategic appointment to support global scale-up of sample management operations

Firstsource Acquires TeleMedik

From Tokyo to Osaka: PSI Continues Japan Expansion with New Office in Osaka

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products

IDT and Ansa announced that Ansa’s Clonal DNA and XL Clonal DNA products, ranging from 100 bp to 50 kb, will be made available to IDT customers. This strategic collaboration enables more researchers to design and assemble longer, more complex constructs for next-generation cell and gene therapy discovery, vaccine research, and agrigenomics applications.

Hongene Biotech Announces Grant to Expand Global Access to mRNA Vaccine Raw Materials

Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting (CINV)

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months

Cycle Pharmaceuticals and Inceptua Group Expand the Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to Include Morocco and Egypt

Cycle and Inceptua have announced the expansion of their partnership to make NITYR® tablets available via a Free Goods Programme for eligible patients with HT-1 and AKU to include Morocco and Egypt.

Verista Expands Automation and Validation Capabilities with Acquisition of Integral Solutions

Verista, a leading provider of automation, compliance, and quality solutions for the life sciences industry, announced the acquisition of Integral Solutions. Based in Columbus, OH, Integral Solutions is a life sciences business and technology services firm that specializes in engineering and validation services worldwide. The acquisition enhances Verista’s capabilities in automation, engineering, project management, and validation, enabling the company to deliver further comprehensive support across the full lifecycle of regulated life sciences operations.

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics 

Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing

PSI Expands Toronto Operations with New Office and Appoints David Allen as Canada Country Manager

Somite Becomes Cellular Intelligence, as It Builds the First Universal Virtual Cell-Signaling Model

New white paper details key technical milestones and validation of the company’s proprietary, capsule-based platform to accelerate breakthroughs across human health

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

● Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asia ● System strengthens Taiwan’s capabilities in protein drug discovery research

PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma

PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform.

Panther Life Sciences Opens Next-Generation Microarray Patch (MAP) Platform to Pharma and Biotech Partners for Co-Development of Advanced Therapies

Panther is inviting pharmaceutical and biotechnology partners to co-develop higher-efficacy, lower-toxicity, shelf-stable therapies using its next-generation MAP platform, ahead of the 2026 JPMorgan Healthcare Conference.

TeleTracking Appoints Derek Ritchea as Chief Strategy Officer

CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media